Invasive pneumococcal disease after implementation of 13-valent pneumococcal conjugate vaccine

被引：0
|
作者：
Kyprianidou, S-A. [1 ]
Mejbri, M. [2 ]
Tornay, A. A. [2 ]
Natterer, J. [3 ]
Greub, G. [4 ]
Crisinel, P-A. [1 ]
Asner, S. [1 ]
机构：
[1] CHU Vaudois, Pediat Infect Dis & Vaccinol Unit, Dept Medicochirurg Pediat, Lausanne, Switzerland
[2] Hop Enfance, Gen Pediat, Lausanne, Switzerland
[3] CHU Vaudois, Pediat Intens Care Unit, Dept Medicochirurg Pediat, Lausanne, Switzerland
[4] CHU Vaudois, Dept Labs, Inst Microbiol, Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2014年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P196
引用
收藏
页码：42S / 43S
页数：2
相关论文
共 50 条
  • [1] Invasive Pneumococcal Disease After Implementation of 13-Valent Conjugate Vaccine
    Tam, Pui-Ying Iroh
    Madoff, Lawrence C.
    Coombes, Brandon
    Pelton, Stephen I.
    [J]. PEDIATRICS, 2014, 134 (02) : 210 - 217
  • [2] Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation
    Levy, Corinne
    Varon, Emmanuelle
    Ouldali, Naim
    Bechet, Stephane
    Bonacorsi, Stephane
    Cohen, Robert
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (03) : 446 - 454
  • [3] Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
    Nikolova, Kristiana Alexandrova
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    [J]. VACCINES, 2021, 9 (10)
  • [4] Infants at Risk for Invasive Pneumococcal Disease in the 13-Valent Pneumococcal Conjugate Vaccine Era
    Yildirim, Inci
    Pelton, Stephen I.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 91 - 92
  • [5] Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults
    Gladstone, Rebecca A.
    Jefferies, Johanna M.
    Faust, Saul N.
    Clarke, Stuart C.
    [J]. EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 889 - 902
  • [6] Insight Into Resistance Phenotypes of Emergent Non 13-valent Pneumococcal Conjugate Vaccine Type Pneumococci Isolated From Invasive Disease After 13-valent Pneumococcal Conjugate Vaccine Implementation in France
    Janoir, Claire
    Lepoutre, Agnes
    Gutmann, Laurent
    Varon, Emmanuelle
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [7] BURDEN OF PNEUMONIA AFTER IMPLEMENTATION OF 13-VALENT CONJUGATE PNEUMOCOCCAL VACCINE
    Strachan, R.
    [J]. RESPIROLOGY, 2019, 24 : 99 - 99
  • [8] Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children
    Varon, Emmanuelle
    Cohen, Robert
    Bechet, Stephane
    Doit, Catherine
    Levy, Corinne
    [J]. VACCINE, 2015, 33 (46) : 6178 - 6185
  • [9] Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
    Alexandrova Nikolova, Kristiana
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    [J]. VACCINES, 2024, 12 (02)
  • [10] Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
    Tomczyk, Sara
    Lynfield, Ruth
    Schaffner, William
    Reingold, Arthur
    Miller, Lisa
    Petit, Susan
    Holtzman, Corinne
    Zansky, Shelley M.
    Thomas, Ann
    Baumbach, Joan
    Harrison, Lee H.
    Farley, Monica M.
    Beall, Bernard
    Mcgee, Lesley
    Gierke, Ryan
    Pondo, Tracy
    Kim, Lindsay
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 62 (09) : 1119 - 1125
12345